Video

Enhancing Communication with Physician Colleagues

discusses effectively communicating with colleagues through patient referral letters. He observes that promptly reporting back to the referring physician is the second most common reason why a physician will receive referrals in the first place. Equally important to swift response is sending clear referral letters that provide the physician with valuable information. Dr. Baum contends that the traditional referral letter is typically too long, slow to arrive, and can be expensive for transcription. Similarly, an electronic copy of patient’s electronic medical record can require too much time to review. Instead, an effective referral letter contains three simple components: diagnosis, medications, and treatment plan recommended. Additionally, physicians should strive to turn around a referral letter before the patient returns to the referring physician for follow up. Dr. Baum offers tips on creating a template referral letter to simplify the process with either preprinted forms or through the patient’s electronic medical record.

Read More

The Wild, Wild West of Radiation Oncology: An Update on Radiation Tools, Toys and Trials

In this 12-minute presentation, Peter F. Orio III, DO, MS, Vice Chair of Network Operations for Dana-Farber/Brigham and Women’s Cancer Center Department of Radiation Oncology and Associate Professor of Radiation Oncology at Harvard Medical School in Boston, Massachusetts, explains prostate brachytherapy is effective, efficient, and convenient, and he says it is “the right thing to do for patients.” He sees a threat to patients posed by radiation oncology without brachytherapy and concludes by encouraging urologists to explore a broad range of treatments to maximize the benefit to patients.

Read More

The Urinary Microbiome and Prostate Disease

In this 17-minute presentation, J. Curtis Nickel, MD, FRCSC, the Canada Research Chair in Urologic Pain and Inflammation and Professor of Urology at Queen’s University in Kingston, Ontario, discusses recent research on the relationship between prostate cancer and the male urinary tract microbiome.

Read More

Forward Progress in Molecular Markers in Prostate Cancer

Matthew R. Cooperberg, MD, MPH, Professor of Urology and Epidemiology & Biostatistics and Helen Diller Family Chair in Urology at the University of California, San Francisco, explores a range of biomarkers used for diagnosis, risk stratification, and guiding treatment for prostate he cancer. He first details pre-biopsy diagnosis or prostate cancer, including PSA, 4K, phi, MyProstateScore, ExoDX, SelectMDx, and mpMRI. Dr. Cooperberg discusses how post-diagnosis biomarkers must be shown to improve on an existing, validated, multivariable model reflecting all available clinical information rather than on a single variable or nonlinear risk grouping, and reviews post-diagnosis options for risk stratification and treatment.

Read More